With regard to antiliver cancer effects, the IgA production pathway of the intestinal immune network induced by APOBEC3F in tumor tissues is inhibited by bufalin, thereby preventing the proliferation of liver tumor cells [25, 26]. Here, CD79A is linked to cancer.